Clinical Trials Browser

Phase 2 × INDUSTRY × Immunoglobulins, Intravenous × Clear all

NCT00294476 2006-10-12

IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma

Phase 2 Unknown

DermatologicGastrointestinalGenitourinary

Colonic Neoplasms, Melanoma, Neoplasms, Urologic Neoplasms